By Adrian Stone, BHSc (Nutritional Medicine), BHSc (Naturopathy), Living Holistic Health — Constipation and Parkinson’s disease are linked years before any tremor. What the gut-first hypothesis says, what the 2026 research found, and what doesn’t hold up.
Your Gut Is Not Like Las Vegas · Part 3 of 5 · Part 1: MS · Part 2: ADHD
Of all the conditions in this series, Parkinson’s disease has the most striking gut story. Not because the gut causes it — nobody has shown that — but because of the timeline. Constipation often shows up years before the first tremor.
That order of events is why Parkinson’s researchers have spent twenty years on one question. Might the disease, in some people, start in the gut and travel upward? It is a genuinely interesting hypothesis. It has also been sold as a settled fact, and this year one of the more hopeful gut treatments failed a proper test. Both halves belong in the same article.
If you or someone close to you has Parkinson’s, here is the other reason to read on: you are going to be offered a lot of gut products. Part 1 set the rule for this series, and it holds here: association is not cause. The gut work that actually helps is unglamorous.

How Strongly Are Constipation and Parkinson’s Disease Linked?
Strongly, and in the direction that matters. A 2022 meta-analysis of 17 studies and more than three million people found constipation carried 2.36 times the odds of a later Parkinson’s diagnosis. In the years before diagnosis, about 20% of people who went on to develop Parkinson’s were constipated, against 11% of controls.
The pooled figure comes with a caveat the authors state plainly. Heterogeneity was high (I² of 90%), driven mainly by study design and disease duration. So the exact size of the odds ratio is soft. The direction is not. Constipation precedes Parkinson’s in a meaningful fraction of people, and it does so by years.
Two things to keep in proportion about constipation and Parkinson’s disease. Most people with constipation will never develop Parkinson’s; it is one of the commonest symptoms in medicine. And Parkinson’s is a diagnosis made by a neurologist on movement signs, not on a bowel history. What the timeline tells us is that the gut is involved early — early enough that it is worth understanding why.
Why Would Parkinson’s Start in the Gut?
Because the protein that clumps in the Parkinson’s brain can appear in the gut wall early, and the nerve connecting the two is a plausible road. In 2003, Heiko Braak proposed that the disease begins in the gut and climbs the vagus nerve to the brainstem. It is still a hypothesis, with evidence on both sides.
The Braak hypothesis
Braak’s staging work mapped where the abnormal alpha-synuclein deposits appear across the course of the disease. The earliest lesions sat in the dorsal motor nucleus of the vagus — the brainstem’s gut-control centre — and in the olfactory system. From there the pathology climbed in a predictable order. The gut-first idea followed naturally. If the earliest brain lesions are in the nerve that talks to the gut, perhaps the process started at the other end of that nerve.
The nerve-cutting evidence
Denmark offered a natural experiment. Truncal vagotomy — cutting the main vagus nerve, once a common ulcer surgery — was compared with a more selective version of the same operation. A registry study followed everyone who had the surgery between 1977 and 1995. Over the whole follow-up the difference was small (hazard ratio 0.85); beyond twenty years it was larger (0.58). The confidence intervals crossed 1 both times, so it is suggestive, not proof. But it is the direction the hypothesis predicts.
The mouse evidence
In 2019, a Johns Hopkins team injected misfolded alpha-synuclein into the gut wall of mice. Over months, the pathology appeared first in the brainstem’s vagal nucleus, then climbed through the regions Braak had mapped. The mice developed motor and non-motor symptoms. Cutting the vagus nerve first prevented both the spread and the symptoms. It is the cleanest demonstration yet that the gut-to-brain route can work — in mice, with injected protein. Whether it is how human Parkinson’s usually begins remains open.
Is the Gut Microbiome Different in Parkinson’s Disease?
Yes, consistently across studies — but the differences are small, and they look a lot like the ones in Part 1. A 2021 meta-analysis re-analysed the ten available datasets and found a shared pattern. More Akkermansia, Lactobacillus and Bifidobacterium. Fewer of the fibre-fermenting families that make short-chain fatty acids.
That meta-analysis is worth pausing on for two reasons. First, the authors are candid that the overall structural difference between Parkinson’s and control microbiomes is small, even though it is robust. Second, the depleted organisms are Faecalibacterium and the Lachnospiraceae family. They are the same butyrate producers that run low in MS, depression and several other conditions in this series. The pattern is not Parkinson’s-specific. It reads as a general marker of a gut that is inflamed, slow, or both.
That raises the obvious chicken-and-egg question. A constipated gut, moving slowly for years, will grow a different set of bacteria whether or not those bacteria did anything to cause the constipation. A 2026 systematic review of the animal models made the same point from the other direction. Motor deficits were reproducible across models. The bacterial changes were inconsistent and poorly matched to the human data. The metabolites — the short-chain fatty acids — translated better than the bacteria did.
Can Changing the Gut Change Parkinson’s?
Not on current evidence, and the most-hyped intervention just failed a proper test. A 2026 meta-analysis of the five randomised trials of faecal microbiota transplantation in Parkinson’s found no significant benefit on motor scores, daily function or cognition. Small trials, short follow-up — so not proof it can’t work, but no sign that it does.
I include that result because the opposite story is everywhere online. “Reset your gut, reverse Parkinson’s” is the single-cause narrative in its purest form, and the trials that would support it do not exist. Faecal transplantation is the most aggressive way to change a microbiome we have. In five randomised trials it did not move movement, daily function or cognition. If that doesn’t do it, a capsule from the health-food aisle is not going to.
What the evidence does support is narrower and more useful. Constipation in Parkinson’s is real, common, and makes life worse. It is treatable as constipation. Fibre, fluid and movement all matter, and so does the timing of meals around medication, as agreed with the prescriber. Your neurologist’s team will have views on the medical options. A 2020 review of probiotic trials in Parkinson’s found the human evidence was mainly about bowel frequency, not the disease itself. That is a modest, honest claim, and it is the one I would make.

Does Diet Matter in Parkinson’s Disease?
The observational evidence says yes, and it points at the same plate as the rest of this series. In a Canadian study of 167 people with Parkinson’s and 119 controls, closer adherence to the MIND diet — a Mediterranean pattern heavy on leafy greens and berries — went with a later age of onset. Cross-sectional, so cause runs both ways.
The paper is small. It cannot separate “diet delayed the disease” from “people who were going to get the disease later ate differently”. But it sits with a broader literature on Mediterranean-style eating and brain ageing, and the mechanism is coherent. Fibre feeds the butyrate producers that run low in Parkinson’s. The diet is low in the ultra-processed foods that slow the gut and feed inflammation. And it is the pattern with the best evidence for the heart and brain generally. Nobody with Parkinson’s loses anything by eating this way.
Should You Get Your Gut Tested for Constipation and Parkinson’s Disease?
Usually not, and never as a way of learning about the Parkinson’s itself. For constipation and Parkinson’s disease together, the history does the work. The microbiome differences here are small and general; no test tells you where you sit on the Braak staircase. A gut test earns its place only for persistent digestive symptoms the basics haven’t shifted.
My rule for any functional test is unchanged — if it will better inform the plan and get you a better result faster, it earns its place. In Parkinson’s, the digestive history usually tells me most of what I need. How long has the constipation been there? What moves it? How does it interact with medication timing? Is there reflux, bloating or weight loss alongside it? Those are the things I can work with. A stool report that says “low Faecalibacterium” tells me what I already know and changes nothing.
Where Does a Naturopath Fit Alongside a Neurologist in Parkinson’s?
Alongside them, in our own lane. We don’t diagnose or treat Parkinson’s disease; that stays with your neurologist and your doctor. Our part is the nutritional, herbal and lifestyle work that sits alongside their care. That means the constipation, the appetite, the weight, the sleep, and the diet quality that a specialist appointment isn’t designed to cover.
Nothing in this article is a reason to change a Parkinson’s medication. The timing of meals around medication is something we work out with the prescriber, never against them. What we add is a gut that moves, a plate that feeds the right bacteria, and a body under less strain — the conditions for the rest of the care to work.
What’s Next in This Series?
Part 4 turns to depression and anxiety. The human evidence for the gut–brain axis there is the largest of any condition in this series, and a landmark Geelong trial showed that changing the diet changed the depression. Same rule: your gut is not like Las Vegas.
Parkinson’s can run for years underground, in the gut, before anyone sees it. That is the reason to take the gut seriously. It is also the reason not to believe anyone who says they can fix the disease from there.
If you’re in Geelong or on the Bellarine and the gut side of Parkinson’s has been left to sort itself out, the first appointment is where we start. Alongside your neurologist, never instead.

Part 1: The gut microbiome and multiple sclerosis
Part 2: ADHD and gut problems
Part 3: Parkinson’s and constipation (this article)
Part 4: Depression, anxiety and the gut-brain axis
Part 5: Autoimmunity beyond MS
Frequently Asked Questions
Is constipation an early sign of Parkinson’s disease?
It can be. Constipation precedes a Parkinson’s diagnosis in about one in five people who develop the disease, often by years, and carries roughly double the odds of a later diagnosis. But constipation is extremely common and most people with it never develop Parkinson’s. New or persistent constipation is a reason to see your GP, not to assume the worst.
Does Parkinson’s start in the gut?
It is a serious hypothesis, not an established fact. The earliest brain lesions sit in the nerve centre that connects to the gut; misfolded protein injected into the gut of mice climbs that nerve; and people who had the nerve cut for ulcer surgery had somewhat lower rates of Parkinson’s. None of this shows that most human Parkinson’s begins that way.
Can a faecal transplant or probiotic treat Parkinson’s?
No. A 2026 meta-analysis of five randomised trials of faecal transplantation found no benefit on movement, daily function or cognition. Probiotic trials in Parkinson’s have mainly shown effects on bowel frequency. Managing constipation is worthwhile in its own right; it is not a treatment for the disease.
What can someone with Parkinson’s do about their gut?
Treat the constipation as a real problem rather than living with it: fibre, fluid, daily movement, meal timing around medication as agreed with the prescriber, and a Mediterranean-style diet that feeds the fibre-fermenting bacteria. Keep all of it alongside the neurologist’s care.
References
Research located via PubMed. All links go to the original papers.
- Yao L, Liang W, Chen J, et al. Constipation in Parkinson’s disease: a systematic review and meta-analysis. Eur Neurol. 2022. https://doi.org/10.1159/000527513
- Braak H, Del Tredici K, Rüb U, et al. Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging. 2003;24(2):197-211. https://doi.org/10.1016/s0197-4580(02)00065-900065-9)
- Svensson E, Horváth-Puhó E, Thomsen RW, et al. Vagotomy and subsequent risk of Parkinson’s disease. Ann Neurol. 2015;78(4):522-529. https://doi.org/10.1002/ana.24448
- Kim S, Kwon SH, Kam TI, et al. Transneuronal propagation of pathologic α-synuclein from the gut to the brain models Parkinson’s disease. Neuron. 2019;103(4):627-641. https://doi.org/10.1016/j.neuron.2019.05.035
- Romano S, Savva GM, Bedarf JR, Charles IG, Hildebrand F, Narbad A. Meta-analysis of the Parkinson’s disease gut microbiome suggests alterations linked to intestinal inflammation. NPJ Parkinsons Dis. 2021;7:27. https://doi.org/10.1038/s41531-021-00156-z
- Elford JD, et al. Gut bacteria composition in animal models of Parkinson’s disease: a systematic review and meta-analysis. NPJ Parkinsons Dis. 2026. https://doi.org/10.1038/s41531-025-01236-0
- Liang Y, et al. Systematic review and meta-analysis of the efficacy of fecal microbiota transplantation in Parkinson’s disease. Rev Neurol. 2026. https://doi.org/10.31083/RN50106
- Metcalfe-Roach A, Yu AC, Golz E, et al. MIND and Mediterranean diets associated with later onset of Parkinson’s disease. Mov Disord. 2021;36(4):977-984. https://doi.org/10.1002/mds.28464
- Tan AH, Hor JW, Chong CW, Lim SY. Probiotics for Parkinson’s disease: current evidence and future directions. JGH Open. 2020;5(4):414-419. https://doi.org/10.1002/jgh3.12450
This article is general information only and is not a substitute for individual medical advice. If you have Parkinson’s disease, please discuss any change to your diet, supplements or lifestyle with your neurologist or GP. For private health consultation claiming, please enquire with your health fund to assess coverage. Nutrition consultations are covered by some private health funds — please check with yours first.